Dr. Gantt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-1909Fax+1 206-987-3890
Education & Training
- University of WashingtonFellowship, Pediatric Infectious Diseases, 2003 - 2006
- University of WashingtonResidency, Pediatrics, 2001 - 2003
- New York University School of MedicineClass of 2001
Certifications & Licensure
- WA State Medical License 2003 - 2015
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma Start of enrollment: 2017 Mar 13
- CT18 Infant Influenza Priming Study in Vaccine Naive Infants Start of enrollment: 2018 Nov 01
Publications & Presentations
PubMed
- 1 citationsA Geographically Weighted Cost-effectiveness Analysis of Newborn Cytomegalovirus Screening.Paul M Lantos, Soren Gantt, Mark Janko, Francois Dionne, Sallie R Permar
Open Forum Infectious Diseases. 2024-06-01 - 8 citationsPrevalence, incidence, and risk factors associated with cytomegalovirus infection in healthcare and childcare worker: a systematic review and meta-analysis.Safari Joseph Balegamire, Elisabeth McClymont, Agathe Croteau, Philippe Dodin, Soren Gantt
Systematic Reviews. 2022-06-27 - 1 citationsCorrigendum to 'Guideline No. 420: Cytomegalovirus Infection in Pregnancy' [Journal of Obstetrics and Gynaecology Canada 43/7 (2021) 893-908].Isabelle Boucoiran, Mark H. Yudin, Vanessa Poliquin, Sheila Caddy, Soren Gantt
Journal of Obstetrics and Gynaecology Canada. 2021-10-11
Press Mentions
- Babies and Toddlers Are Getting COVID-19 Vaccines in Montreal as Part of a Clinical TrialNovember 25th, 2021
- UBC Faculty of Medicine Researchers Receive Nearly $14M in Federal Funding for COVID-19 ResearchJune 25th, 2020
- Cytomegalovirus Vaccine Candidate Found to Be Safe & Immunogenic in First-in-Humans TrialOctober 11th, 2018
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: